Boston Scientific (BSX) Cash from Investing Activities (2009 - 2026)

Boston Scientific has disclosed Cash from Investing Activities across 18 years of filings, most recently posting -$2.0 billion for Q2 2026.

• In Q2 2026, Cash from Investing Activities fell 73.71% year-over-year to -$2.0 billion; the TTM figure through Jun 2026 stood at -$3.6 billion (up 47.3% YoY), while the FY2025 annual figure was -$2.6 billion, up 53.58% from the prior year.
• Cash from Investing Activities came in at -$2.0 billion for Q2 2026 at Boston Scientific, down from -$591.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$29.0 million in Q2 2022 to a low of -$3.7 billion in Q4 2024.
• Average Cash from Investing Activities over 5 years is -$858.8 million, with a median of -$507.0 million recorded in 2025.
• Year-over-year, Cash from Investing Activities plunged 2796.55% in 2023 and soared 86.18% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$183.0 million in 2022, then tumbled by 475.41% to -$1.1 billion in 2023, then slumped by 251.76% to -$3.7 billion in 2024, then soared by 86.18% to -$512.0 million in 2025, then tumbled by 282.03% to -$2.0 billion in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$2.0 billion in Q2 2026, -$591.0 million in Q1 2026, and -$512.0 million in Q4 2025.